Detalles de la búsqueda
1.
Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical Models.
Cancer Res
; 75(12): 2489-500, 2015 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25870145
2.
AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer.
Cancer Discov
; 4(9): 1046-61, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24893891
3.
HER2 amplification: a potential mechanism of acquired resistance to EGFR inhibition in EGFR-mutant lung cancers that lack the second-site EGFRT790M mutation.
Cancer Discov
; 2(10): 922-33, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22956644
Resultados
1 -
3
de 3
1
Próxima >
>>